Tag: Nature-Neuroscience

4 articles

Research

UCSF brain-computer interface decodes speech and body gestures simultaneously from a single cortical implant

A Nature Neuroscience paper published on 14 September 2026 by Samantha C. Brosler, Jessie R. Liu, Alexander B. Silva and senior author Edward F. Chang at UCSF reports the first single-implant, single-session, real-time simultaneous decoding of speech and upper-body gestures in people with paralysis. Two of three BRAVO-trial participants (Bravo-1r, brainstem stroke, seven years enrolled; Bravo-6, ALS, implanted March 2025) controlled a personalized virtual avatar with parallel speech and gesture decoders reading from a 253-channel high-density ECoG surface array manufactured by PMT Corporation. Bravo-1r reached median 100 percent accuracy on both decoders in the real-time conversation paradigm; Bravo-6 reached 85 percent gesture and 75 percent speech. The design finding is that multimodal neural signals are not the linear sum of isolated speech and gesture signals: decoders trained on simultaneous data outperform decoders trained on isolated data, and cross-training drops opposite-modality false-positive rates from 76 percent (Bravo-1r) and 31 percent (Bravo-6) to zero. Chang has stated a fully implantable wireless successor is the next step. Hardware footprint is PMT surface ECoG plus a Blackrock Neurotech digital headstage per prior Chang-lab methods, with no overlap with Neuralink Threads, Paradromics Connexus, or Synchron Stentrode. This is the fourth UCSF Chang-lab BRAVO paper in the peer-reviewed communication-BCI sequence: Moses NEJM 2021, Metzger Nature 2023, Littlejohn Nature Neuroscience 2025, Brosler Nature Neuroscience 2026.

Sep 18

Industry News

Paradromics's first Connexus participant used a brain implant to speak her own words

Paradromics announced on 14 September 2026 that the first participant in its Connect-One Early Feasibility Study, a Michigan woman in her 60s with progressive motor neuron disease and severe dysarthria, has used the Connexus intracortical brain-computer interface to generate her own words, answer open-ended questions, and hold a live phone call with her grandchildren, three months after her June 2026 implant at University of Michigan Health. Verbatim first sentence: 'Okay, I have a lot to say.' Second sentence: 'Don't be afraid. It's a wonderful experience to be able to help others by your participation in the research study.' Both were decoded in real time, word for word, with no errors, according to Paradromics. Output modality is text plus synthesized speech (not avatar-mediated). Quantitative benchmarks (words per minute, word-error rate, vocabulary size, decoding latency) were not disclosed. The Connect-One EFS runs across three sites (University of Michigan Health, UC Davis Health, Mass General Brigham) under FDA IDE approval granted in November 2025. Same-day academic milestone at UCSF (Edward Chang team, Nature Neuroscience) demonstrates simultaneous speech and gesture decoding via animated avatar. The two results are categorically different (commercial vs academic, text-plus-audio vs avatar-mediated) and should not be conflated.

Sep 16

Policy & Regulation

Four senior BCI neurosurgeon-scientists use Nature Neuroscience to press for tighter research ethics as implant numbers scale

Four clinician-scientists from Mayo Clinic, University College London, and Sichuan University published a Comment in Nature Neuroscience on 7 September 2026 setting out four ethical priorities for implantable brain-computer interface research: separating research participation from patient care, ensuring long-term support for study participants, avoiding disproportionate risks to participants for benefits realised mainly by others, and grounding research in meaningful clinical purpose. Lead author Kai J. Miller (Mayo Clinic) is the corresponding author. Senior author Gerwin Schalk (West China Hospital, Sichuan University) is the second corresponding author. Co-author Harith Akram (UCL Queen Square) declares a conflict of interest as Chief Investigator of Neuralink's GB-PRIME UK study. The Comment lands one day after Germany's outgoing federal data protection commissioner pressed Europe for tighter rules on bidirectional BCI, and ten months after UNESCO's General Conference adopted the first global standard on the ethics of neurotechnology in November 2025.

Sep 8